Theranexus (France) Today
| ALTHX Stock | EUR 0.58 0.01 1.69% |
Performance3 of 100
| Odds Of DistressOver 68
|
Theranexus is selling at 0.58 as of the 30th of December 2024; that is 1.69% down since the beginning of the trading day. The stock's last reported lowest price was 0.57. Theranexus has more than 68 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 1st of October 2024 and ending today, the 30th of December 2024. Click here to learn more.
Theranexus socit anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company was founded in 2013 and is based in Lyon, France. THERANEXUS is traded on Paris Stock Exchange in France. The company has 5.32 M outstanding shares. More on Theranexus SA
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Theranexus Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Theranexus' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Theranexus or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman of the Board, CEO | Franck Mouthon |
| Business Concentration | Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) |
Theranexus SA (ALTHX) is traded on Euronext Paris in France and employs 19 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Theranexus's market, we take the total number of its shares issued and multiply it by Theranexus's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Theranexus SA operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 5.32 M outstanding shares.
Theranexus SA has accumulated about 7.01 M in cash with (6.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.86, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Theranexus Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Theranexus is €10.3 Million. Theranexus SA has significant amount of outstanding shares owned by insiders and institutional investors .Since such a large part of the company is not owned by regular investors, we recommend to check if there were significant buying or selling the Theranexus SA stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Theranexus Ownership Details
Theranexus SA Risk Profiles
Although Theranexus' alpha and beta are two of the key measurements used to evaluate Theranexus' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.65 | |||
| Semi Deviation | 2.34 | |||
| Standard Deviation | 5.75 | |||
| Variance | 33.08 |
Theranexus Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Theranexus without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Theranexus Corporate Management
Elected by the shareholders, the Theranexus' board of directors comprises two types of representatives: Theranexus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Theranexus. The board's role is to monitor Theranexus' management team and ensure that shareholders' interests are well served. Theranexus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Theranexus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Julien Veys | Chief Business Development Officer | Profile | |
| Francoise VincentLarrode | Director HR | Profile | |
| Marie Sebille | Chief Officer | Profile | |
| Mathieu Charvriat | Deputy Officer | Profile |
Additional Tools for Theranexus Stock Analysis
When running Theranexus' price analysis, check to measure Theranexus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theranexus is operating at the current time. Most of Theranexus' value examination focuses on studying past and present price action to predict the probability of Theranexus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theranexus' price. Additionally, you may evaluate how the addition of Theranexus to your portfolios can decrease your overall portfolio volatility.